Trial Profile
Mosapride vs teprenone in Japanese patients with functional dyspepsia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Mosapride (Primary) ; Teprenone (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- Acronyms JMMS
- 22 Dec 2011 New trial record